Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 221-228

  Tamura, Gen ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Age related methylation; Gastric cancer; Promoter hypermethylation; Tumor suppressor gene

Indexed keywords

ACTIVATED PROTEIN C; CELL ADHESION MOLECULE; DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P16; TRANSCRIPTION FACTOR RUNX3; UVOMORULIN;

AGE; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; CELL AGING; DISEASE PREDISPOSITION; HUMAN; METHYLATION; MOLECULAR GENETICS; NONHUMAN; PHYSIOLOGY; PREDICTION; PROMOTER REGION; REVIEW; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGING; ANIMALS; DNA METHYLATION; DNA, NEOPLASM; EPITHELIAL CELLS; GASTRIC MUCOSA; GENES, TUMOR SUPPRESSOR; HUMANS; INCIDENCE; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS;

EID: 1642474373     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Becker K-F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.R. and Hofler H. (1994). E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54, 3845-3852.
2. Byun D.S., Lee M.G., Chae K.S., Ryu B.G. and Chi S.G. (2001). Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res. 61, 7034-7038.
3. Cohen O. and Kimichi A. (2001). DAP-kinase: From functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Diff. 8, 6-15.
4. Dammann R., Li C., Yoon J.H., Chin P.L. and Bates S. and Pfeifer G.P. (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25, 315-319.
5. Dammann R., Schagdarsurengin U., Strunnikova M., Rastetter M., Seidel C., Liu L., Tommasi S. and Pfeifer G.P. (2003). Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol. 18, 665-677.
6. Endoh Y., Tamura G., Watanabe H., Ajioka Y. and Motoyama T. (2000). Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am. J. Pathol. 157, 717-722.
7. Esteller M., Corn P.G., Baylin S.B. and Herman J.G. (2001). A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229.
8. Fleisher A.S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T-T., Abraham J.M., Kong D., Smolinski K.N., Shi Y-Q., Rhyu M-G., Powell S.M., James S.P., Wilson K.T., Herman J.G. and Meltzer S.J. (1999). Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59, 1090-1095.
9. Fleisher A.S., Esteller M., Tamura G., Rashid A., Stine O.C., Yin J., Zou T-T., Abraham J.M., Kong D., Nishizuka S., James S.P., Wilson K.T., Herman J.G. and Meltzer S.J. (2001). Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 20, 329-335.
10. Hedrick L., Cho K.R., Fearon E.R., Wu T.C., Kinzler K.W. and Vogelstein B. (1994). The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev. 8, 1174-1183.
11. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D. and Baylin S.B. (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530.
12. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D. and Baylin S.B. (1996). Methylation-specific PCR: A novel PCR assay for methylation status for CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826.
13. Hirohashi S. (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153, 333-339.
14. Honda T., Tamura G., Waki T., Jin Z., Sato K., Motoyama T., Kimura W., Kawata S., Nishizuka S. and Murakami Y. (2002). Hypermethylation of TSLC1 gene promoter in gastric cancer. Jpn. J. Cancer Res. 93, 857-860.
15. Issa J.P. (2000). CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol. 249. 101-118.
16. Jin Z., Tamura G., Tsuchiya T., Sakata K., Kashiwaba M., Osakabe M. and Motoyama T. (2001). Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br. J. Cancer. 85, 69-73.
17. Jin Z., Tamura G., Honda T. and Motoyama T. (2002). Molecular and cellular phenotypic profiles of gastric non-invasive neoplasia. Lab. Invest. 82, 1637-1645.
18. Kanai Y., Oda T., Tsuda H., Ochiai A. and Hirohashi S. (1994). Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn. J. Cancer Res. 85, 1035-1039.
19. Kang G.H., Shim Y.H., Jung H.Y., Kim W.H., Ro J.Y. and Rhyu M.G. (2001). CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61, 2847-2851.
20. Kang G.H., Lee S., Kim W.H., Lee H.W., Kim J.C., Rhyu M.G. and Ro J.Y. (2002). Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of myltiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol. 160, 787-794.
21. Kang Y.H., Lee H.S. and Kim W.H. (2002). Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 82, 285-291.
22. Kuramochi M., Fukuhara H., Nobukuni T., Kanbe T., Maruyama T., Ghosh H.P., Pletcher M., Isomura M., Onizuka M., Kitamura T., Sekiya T., Reeves R.H. and Murakami Y. (2001). TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat. Genet. 27, 427-430.
23. Lee J.H., Abraham S.C., Kim H.S., Nam J.H., Choi C., Lee M.C., Park C.S., Juhng S.W., Rashid A., Hamilton S.R. and Wu T.T. (2002). Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am. J. Pathol. 161, 611-618.
24. Lee T.L., Leung W.K., Chan M.W., Ng E.K., Tong J.H., Lo K.W., Chung S.C., Sung J.J. and To K.F. (2002). Detection of gene promoter hypermethylatin in the tumor and serum of patients with gastric carcinoma. Clin. Cancer Res. 8, 1761-1766.
25. Lee W.H., Morton R.A., Epstein J.I., Brooks J.D., Campbell P.A., Bova G.S., Hsieh W.S., Isaacs W.B. and Nelson W.G. (1994). Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91, 11733-11737.
26. Leung W.K., Yu J., Ng E.K., To K.F., Ma P.K., Lee T.L., Go M.Y., Chung S.C. and Sung J.J. (2001). Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91, 2294-2301.
27. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H. and Parsons R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
28. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C. and Ito Y. (2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124.
29. Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., Aoki T., Miki Y., Mori T. and Nakamura Y. (1992). Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum. Mol. Genet. 1, 229-233.
30. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B. and Kinzler K.W. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790.
31. Nakagawa H., Nuovo G.J., Zervos E.E., Martin E.W. Jr., Salovaara R., Aaltonen L.A. and De La Chapelle A. (2001). Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res. 61, 6991-6995.
32. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S. and Hedge P. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669.
33. Ogasawara S., Tamura G., Maesawa C. and Satodate R. (1994). Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas. Virchows Arch. 424, 607-611.
34. Paz M.F., Avila S., Fraga M.F., Pollan M., Capella G., Peinado M.A., Sanchez-Cespedes M., Herman J.G. and Esteller M. (2002). Germaline variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 62, 4519-4524.
35. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G. and Esteller M. (2003). A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63, 1114-1121.
36. Sakata K., Tamura G., Ogata S., Ohmura K., Endoh Y. and Motoyama T. (2002). Hypermethylation of hMLH1 promoter in solitary and multiple gastric cancers with microsatellite instability. Br. J. Cancer 86, 564-567.
37. Sato K., Tamura G., Tsuchiya T., Endoh Y., Usuba O., Kimura W. and Motoyama T. (2001). Frequent loss of expression without sequence mutations in the DCC gene in gastric cancer. Br. J. Cancer 85, 199-203. 2847-2851.
38. Sato K., Tamura G., Tsuchiya T., Endoh Y., Sakata K., Usuba O., Kimura W., Terashima M., Nishizuka S., Zou T., Meltzer S.J. and Motoyama T. (2002). Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch. 440, 160-165.
39. Satoh A., Toyota M., Itoh F., Kikuchi T., Obata T., Sasaki Y., Suzuki H., Yawata A., Kusano M., Fujita M., Hosokawa M., Yanagihara K., Tokino T. and Imai K. (2002). DNA methylation and histone deacetylation associated with silencing DAP-kinase gene expression in colorectal and gastric cancers. Br. J. Cancer 86, 1817-1823.
40. Serrano M., Hannon G.J. and Beach D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
41. Sparks A.B., Morin P.J., Vogelstein B. and Kinzler K.W. (1998). Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130-1134.
42. Suzuki H., Itoh F., Toyota M., Kikuchi T., Kakiuchi H., Hinoda Y. and Imai K. (1999). Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int. J. Cancer 83, 309-313.
43. Tamura G. (2002). Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol. Histopathol. 17, 323-329.
44. Tamura G., Maesawa C., Suzuki Y., Tamada H., Satoh M., Ogasawara S., Kashiwaba M. and Satodate R. (1994). Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res. 54, 1149-1151.
45. Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Iwaya T., Terashima M., Saito K. and Satodate R. (1996). Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn. J. Cancer Res. 87, 1153-1159.
46. Tamura G., Yin J., Wang S., Fleisher A.S., Zou T-T., Abraham J.M., Kong D., Smolinski K.N., Wilson K.T., James S.P., Silverberg S.G., Nishizuka S., Terashima M., Motoyama T. and Meltzer S.J. (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl. Cancer Inst. 92, 569-573.
47. Tamura G., Sato K., Akiyama S., Tsuchiya T., Endoh Y., Usuba O., Kimura W., Nishizuka S. and Motoyama T. (2001). Molecular characterization of undifferentiated-type gastric carcinoma. Lab. Invest. 81, 593-598.
48. To K.F., Leung W.K., Lee T.L., Yu J., Tong J.H.M., Chan M.W.Y., Ng E.K.W., Chung S.C.S. and Sung J.J.Y. (2002). Sung promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int. J. Cancer 102, 623-628.
49. Toyota M., Ahuja N., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., Baylin S.B. and Issa J.P. (1999a). Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438-5442.
50. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B. and Issa J.P. (1999b). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96, 8681-8686.
51. Tsuchiya T., Tamura G., Sato K., Endoh Y., Sakata K., Jin Z., Motoyama T., Usuba O., Kimura W., Nishizuka S., Wilson K.T., James S.P., Yin J., Fleisher A.S., Zou T., Kong D., Silverberg S.G. and Meltzer S.J. (2000). Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19, 3642-3646.
52. Waki T., Tamura G., Tsuchiya T., Sato K., Nishizuka S. and Motoyama T. (2002). Promoter methylation status of E-cadherin, hMLH1 and p16 genes in non-neoplastic gastric epithelia. Am. J. Pathol. 161, 399-403.
53. Waki T., Tamura G., Sato M., Terashima M., Nishizuka S. and Motoyama T. (2003a). Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci. 94, 360-364.
54. Waki T., Tamura G., Sato M. and Motoyama T. (2003b). Age-related methylation of tumor suppressor and tumor-related genes: An analysis of autopsy samples. Oncogene 22, 4128-4133.
55. Zysman M.A., Chapman W.B. and Bapat B. (2002). Considerations when analyzing the methylation status of PTEN tumor suppressor gene. Am. J. Pathol. 160, 795-800.